Plasma glutamate--a prognostic marker of cancer and of other immunodeficiency syndromes?

@article{Ollenschlaeger1989PlasmaGP,
  title={Plasma glutamate--a prognostic marker of cancer and of other immunodeficiency syndromes?},
  author={Guenter Ollenschlaeger and Josef Karner and Judith Karner-Hanusch and Stephen T. Jansen and Joshua Schindler and Erich George Roth},
  journal={Scandinavian journal of clinical and laboratory investigation},
  year={1989},
  volume={49 8},
  pages={
          773-7
        }
}
Elevated plasma levels of glutamate (GLU) have been reported to occur in patients with malignancies and other immunodeficiency syndromes (IDS). To evaluate, whether GLU is useful as prognostic indicator, the plasma concentrations were determined in patients with colorectal carcinoma (CRC), with breast cancer (BRC), and with HIV-infection (HIV). The results were correlated with the disease-stages, and compared with data obtained from patients with benign diseases of the same organ, as well as… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 13 CITATIONS

New role of glutamate as an immunoregulator via glutamate receptors and transporters.

  • Frontiers in bioscience
  • 2011
VIEW 8 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Glutamate, T cells and multiple sclerosis

  • Journal of Neural Transmission
  • 2016
VIEW 1 EXCERPT
CITES BACKGROUND

Oncodynamics: Effects of Cancer Cells on the Body

  • Springer International Publishing
  • 2016
VIEW 2 EXCERPTS
CITES BACKGROUND

Similar Papers

Loading similar papers…